Duvelisib Ameliorates Manifestations of Pneumonia in Established Novel Coronavirus Infection (COVID-19)
Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
Participant gender:
Summary
In this study, a total of 80 patients with severe coronavirus disease 2019 (COVID-19)
infection will be randomized to receive Duvelisib or a placebo. Participants will be enrolled
at Emory University Hospital and at the University of Pennsylvania and will be identified and
recruited by their treating physician and research team.